Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy
Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma
Read the full report on The Hindu
Story file
- Section
- India
- Topics
- Cars & bikes
- First reported by
- The Hindu
- Published
- Wednesday, 21 October 2026, 3:20 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from The Hindu with a short summary and a link to the original. The original reporting belongs to the publisher. Spotted an error in our summary? Tell our corrections desk.






